ICCC vs PCG · rev $26.5M vs P/E 13, $37.68B cap
ImmuCell Corporation (ICCC) versus PG&E Corp (PCG) — a side-by-side from cached financials, not a winner call.
ImmuCell Corporation (ICCC) is a biotechnology company listed on US.
PG&E Corp (PCG) is a utilities - regulated electric company listed on US.
Latest reported ICCC revenue for 2024-12-31 was $26.5M. Net income was -$2.2M. Revenue was up 51.6% from 2023-12-31 to 2024-12-31. ICCC currently screens at market cap $58.9M.
PCG does not have a complete income-statement cache yet.
ICCC currently screens at market cap $58.9M. PCG currently screens at market cap $37.68B and trailing P/E 13.3.
Not investment advice. Open the ICCC and PCG stock pages for the full models.
Not investment advice.